Telemus Capital, LLC Abbott Laboratories Transaction History

Telemus Capital, LLC

  • $1.2 Billion
  • Q4 2023

A detailed history of Telemus Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Telemus Capital, LLC holds 67,144 shares of ABT stock, worth $7.91 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
67,144
Previous 65,922 1.85%
Holding current value
$7.91 Million
Previous $6.38 Million 15.76%
% of portfolio
0.62%
Previous 0.6%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024
BUY
$90.19 - $110.4 $110,212 - $134,908
1,222 Added 1.85%
67,144 $7.39 Million
Q3 2023

Oct 25, 2023
SELL
$95.53 - $114.62 $48,720 - $58,456
-510 Reduced 0.77%
65,922 $6.38 Million
Q2 2023

Jul 10, 2023
SELL
$100.78 - $112.29 $79,011 - $88,035
-784 Reduced 1.17%
66,432 $7.24 Million
Q1 2023

Apr 11, 2023
BUY
$96.86 - $114.01 $107,127 - $126,095
1,106 Added 1.67%
67,216 $6.81 Million
Q4 2022

Jan 11, 2023
SELL
$95.06 - $111.52 $21,103 - $24,757
-222 Reduced 0.33%
66,110 $0
Q3 2022

Oct 11, 2022
BUY
$96.76 - $112.03 $47,122 - $54,558
487 Added 0.74%
66,332 $6.42 Million
Q2 2022

Aug 10, 2022
SELL
$102.07 - $123.37 $386,130 - $466,708
-3,783 Reduced 5.43%
65,845 $7.15 Million
Q1 2022

Apr 06, 2022
SELL
$114.02 - $139.04 $60,772 - $74,108
-533 Reduced 0.76%
69,628 $8.24 Million
Q4 2021

Feb 01, 2022
BUY
$115.53 - $141.46 $69,202 - $84,734
599 Added 0.86%
70,161 $9.87 Million
Q3 2021

Oct 27, 2021
SELL
$116.66 - $129.06 $11,666 - $12,906
-100 Reduced 0.14%
69,562 $8.22 Million
Q2 2021

Aug 09, 2021
SELL
$105.79 - $124.53 $1.33 Million - $1.56 Million
-12,559 Reduced 15.27%
69,662 $8.08 Million
Q1 2021

Apr 20, 2021
BUY
$108.84 - $128.23 $85,657 - $100,917
787 Added 0.97%
82,221 $9.86 Million
Q4 2020

Jan 28, 2021
SELL
$105.0 - $114.42 $501,585 - $546,584
-4,777 Reduced 5.54%
81,434 $8.92 Million
Q3 2020

Nov 02, 2020
SELL
$91.64 - $111.29 $152,580 - $185,297
-1,665 Reduced 1.89%
86,211 $9.46 Million
Q2 2020

Jul 17, 2020
SELL
$76.57 - $98.0 $121,057 - $154,938
-1,581 Reduced 1.77%
87,876 $8.18 Million
Q1 2020

Jun 05, 2020
SELL
$62.82 - $91.86 $222,005 - $324,633
-3,534 Reduced 3.8%
89,457 $8.49 Million
Q4 2019

Jan 24, 2020
SELL
$78.51 - $87.4 $688,454 - $766,410
-8,769 Reduced 8.62%
92,991 $8.08 Million
Q3 2019

Nov 12, 2019
BUY
$81.84 - $88.74 $35,764 - $38,779
437 Added 0.43%
101,760 $8.51 Million
Q2 2019

Aug 09, 2019
BUY
$72.88 - $85.0 $389,543 - $454,325
5,345 Added 5.57%
101,323 $8.43 Million
Q1 2019

May 02, 2019
SELL
$66.22 - $80.06 $285,143 - $344,738
-4,306 Reduced 4.29%
95,978 $7.67 Million
Q4 2018

Feb 06, 2019
BUY
$65.56 - $74.27 $3.5 Million - $3.96 Million
53,356 Added 113.7%
100,284 $7.25 Million
Q3 2018

Oct 23, 2018
BUY
$60.81 - $73.36 $214,902 - $259,254
3,534 Added 8.14%
46,928 $3.44 Million
Q2 2018

Jul 31, 2018
SELL
$57.57 - $63.54 $38,053 - $41,999
-661 Reduced 1.5%
43,394 $2.65 Million
Q1 2018

Apr 27, 2018
SELL
$56.27 - $63.62 $25,996 - $29,392
-462 Reduced 1.04%
44,055 $2.64 Million
Q4 2017

Feb 02, 2018
BUY
$53.68 - $57.47 $815,936 - $873,544
15,200 Added 51.85%
44,517 $2.54 Million
Q3 2017

Nov 03, 2017
SELL
$48.06 - $53.64 $12,976 - $14,482
-270 Reduced 0.91%
29,317 $1.56 Million
Q2 2017

Apr 03, 2018
BUY
N/A
475 Added 1.63%
29,587 $1.44 Million
Q1 2017

Apr 03, 2018
BUY
N/A
29,112
29,112 $1.29 Million

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Telemus Capital, LLC Portfolio

Follow Telemus Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email